Explore Imagine Create
The Future of Targeted Medicine

Developing cures for untreatable diseases through the discovery of active micro RNAs.

We are a Biotech-startup focused on developing novel genetic therapies.
Our goal is to develop novel therapies that target only cells causing a disease, with minimal patient burden.
We create the future where our therapies allow patients to live healthier and more fulfilling lives.
We believe our ingenuity and curiosity can lead us to the future.

RNA Design

Our patented RNA Switch technology enables us to develop novel therapies that control therapeutic effect in a cell-specific manner.

News

Notice of Change in President & CEO

As of May 26th, Teruo Susumu has resigned from his position as President and CEO at aceRNA Technologies. Fumihiro Sugawa will serve as the new President and CEO. We will continue to develop “smart gene therapy” (mRNA-based and virus-base) that enables control of therapeutic transgene expression in cell-type and -state specific manner.

We and Nitto Denko entered into an agreement to jointly develop Switch mRNA Therapy

Related link: Press release

Close of Series B funding

aceRNA Technologies has raised funds from Nitto Denko and Mitsubishi UFJ Capital. aceRNA will use this capital to develop “smart gene therapy” (mRNA-based and virus-base) that enables
control of therapeutic transgene expression in cell-type and -state specific manner.

We seek patnerships!

We are looking to develop revolutionary new treatments with partner companies using RNA Switches.

More details
     

Recruit

Join our quest to discover and develop novel therapies.

It is a work that takes boundless imagination and curiosity.
One idea can lead us to a new cure.
One can dream to change the course of humanity.
We are looking for like-minded individuals who would join our endeavor.